244 related articles for article (PubMed ID: 33784590)
1. Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes.
Dieters-Castator D; Dantonio PM; Piaseczny M; Zhang G; Liu J; Kuljanin M; Sherman S; Jewer M; Quesnel K; Kang EY; Köbel M; Siegers GM; Leask A; Hess D; Lajoie G; Postovit LM
Neoplasia; 2021 Apr; 23(4):375-390. PubMed ID: 33784590
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
3. Nodal Facilitates Differentiation of Fibroblasts to Cancer-Associated Fibroblasts that Support Tumor Growth in Melanoma and Colorectal Cancer.
Li Z; Zhang J; Zhou J; Lu L; Wang H; Zhang G; Wan G; Cai S; Du J
Cells; 2019 Jun; 8(6):. PubMed ID: 31167491
[TBL] [Abstract][Full Text] [Related]
4. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
Frisbie L; Buckanovich RJ; Coffman L
Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
[TBL] [Abstract][Full Text] [Related]
6. Nodal signaling promotes a tumorigenic phenotype in human breast cancer.
Kirsammer G; Strizzi L; Margaryan NV; Gilgur A; Hyser M; Atkinson J; Kirschmann DA; Seftor EA; Hendrix MJ
Semin Cancer Biol; 2014 Dec; 29():40-50. PubMed ID: 25073112
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
8. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
10. The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells.
Ryan D; Paul BT; Koziol J; ElShamy WM
Breast Cancer Res; 2019 Apr; 21(1):53. PubMed ID: 31014367
[TBL] [Abstract][Full Text] [Related]
11. Type 2 Diabetes Mellitus Promotes the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells into Cancer-Associated Fibroblasts, Induced by Breast Cancer Cells.
Chang YH; Ngo NH; Vuong CK; Yamashita T; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2022 Nov; 31(21-22):659-671. PubMed ID: 35734905
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell secretome and regenerative therapy after cancer.
Zimmerlin L; Park TS; Zambidis ET; Donnenberg VS; Donnenberg AD
Biochimie; 2013 Dec; 95(12):2235-45. PubMed ID: 23747841
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
14. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment.
Zhang T; Tseng C; Zhang Y; Sirin O; Corn PG; Li-Ning-Tapia EM; Troncoso P; Davis J; Pettaway C; Ward J; Frazier ML; Logothetis C; Kolonin MG
Nat Commun; 2016 May; 7():11674. PubMed ID: 27241286
[TBL] [Abstract][Full Text] [Related]
15. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.
Chauhan A; Agarwal S; Masih M; Gautam PK
Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117
[TBL] [Abstract][Full Text] [Related]
16. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
[TBL] [Abstract][Full Text] [Related]
17. Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment.
Bodenstine TM; Chandler GS; Reed DW; Margaryan NV; Gilgur A; Atkinson J; Ahmed N; Hyser M; Seftor EA; Strizzi L; Hendrix MJ
Cell Cycle; 2016 May; 15(9):1295-302. PubMed ID: 27007464
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer.
Camorani S; Hill BS; Fontanella R; Greco A; Gramanzini M; Auletta L; Gargiulo S; Albanese S; Lucarelli E; Cerchia L; Zannetti A
Theranostics; 2017; 7(14):3595-3607. PubMed ID: 28912898
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade.
Antoon R; Wang XH; Saleh AH; Warrington J; Hedley DW; Keating A
Cytotherapy; 2022 Jul; 24(7):699-710. PubMed ID: 35473998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
